New study tests VIGIV for rare smallpox vaccine side effects
NCT ID NCT01374984
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This study looks at how well VIGIV (a medicine made from antibodies) works for people who have serious side effects from the smallpox vaccine. About 100 patients will be treated and followed to see if their skin lesions get better. The goal is to confirm the benefits of this treatment for rare vaccine complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLICATION OF SMALLPOX VACCINATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.